Modifying the Poor Prognosis Associated with 18F-FDG-Avid NET with Peptide Receptor Chemo-Radionuclide Therapy (PRCRT)

被引：13
作者：
Hofman, Michael S. [1 ]
Michael, Michael [1 ]
Kashyap, Raghava [1 ]
Hicks, Rodney J. [1 ]
机构：
[1] Peter MacCallum Canc Ctr, East Melbourne, Vic 3002, Australia
来源：
JOURNAL OF NUCLEAR MEDICINE | 2015年 / 56卷 / 06期
关键词：
NEUROENDOCRINE TUMORS; ENDOCRINE TUMORS; LU-177-OCTREOTATE; TOXICITY; PET;
D O I：
10.2967/jnumed.115.154500
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：968 / 969
页数：2
相关论文
共 8 条
[1]   High Prognostic Value of 18F-FDG PET for Metastatic Gastroenteropancreatic Neuro endocrine Tumors: A Long-Term Evaluation [J].
Bahri, Haifa ;
Laurence, Lenoir ;
Edeine, Julien ;
Leghzali, Houda ;
Devillers, Anne ;
Raoul, Jean-Luc ;
Cuggia, Marc ;
Mesbah, Habiba ;
Clement, Bruno ;
Boucher, Eveline ;
Garin, Etienne .
JOURNAL OF NUCLEAR MEDICINE, 2014, 55 (11) :1786-1790
[2]   18F-Fluorodeoxyglucose Positron Emission Tomography Predicts Survival of Patients with Neuroendocrine Tumors [J].
Binderup, Tina ;
Knigge, Ulrich ;
Loft, Annika ;
Federspiel, Birgitte ;
Kjaer, Andreas .
CLINICAL CANCER RESEARCH, 2010, 16 (03) :978-985
[3]   Phase I-II Study of Radiopeptide 177Lu-Octreotate in Combination with Capecitabine and Temozolomide in Advanced Low-Grade Neuroendocrine Tumors [J].
Claringbold, Phillip G. ;
Price, Richard A. ;
Turner, J. Harvey .
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2012, 27 (09) :561-569
[4]   Predictive Value of 18F-FDG PET and Somatostatin Receptor Scintigraphy in Patients with Metastatic Endocrine Tumors [J].
Garin, Etienne ;
Le Jeune, Florence ;
Devillers, Anne ;
Cuggia, Marc ;
de Lajarte-Thirouard, Anne-Sophie ;
Bouriel, Catherine ;
Boucher, Eveline ;
Raoul, Jean-Luc .
JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (06) :858-864
[5]   Peptide receptor radionuclide therapy for neuroendocrine tumours: standardized and randomized, or personalized? [J].
Hofman, Michael S. ;
Hicks, Rodney J. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (02) :211-213
[6]  
Hofman MS, 2012, DISCOV MED, V14, P71
[7]   Rapid blood clearance and lack of long-term renal toxicity of 177Lu-DOTATATE enables shortening of renoprotective amino acid infusion [J].
Kashyap, Raghava ;
Jackson, Price ;
Hofman, Michael S. ;
Eu, Peter ;
Beauregard, Jean-Mathieu ;
Zannino, Diana ;
Hicks, Rodney J. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (12) :1853-1860
[8]   Hematological Toxicity of Combined 177Lu-Octreotate Radiopeptide Chemotherapy of Gastroenteropancreatic Neuroendocrine Tumors in Long-Term Follow-Up [J].
Kesavan, Murali ;
Claringbold, Phillip G. ;
Turner, J. Harvey .
NEUROENDOCRINOLOGY, 2014, 99 (02) :108-117
1